Association Between CYP2D6 Metabolizer Status and Vortioxetine Exposure and Treatment Switching
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Clinical Psychopharmacology"
DOI: 10.1097/jcp.0000000000001563
Abstract: Abstract Purpose The antidepressant vortioxetine is mainly metabolized by the polymorphic enzyme CYP2D6. The aim of this study was to investigate the absolute serum concentrations of vortioxetine and frequency of switching to an alternative antidepressant… read more here.
Keywords: vortioxetine exposure; association cyp2d6; cyp2d6; vortioxetine ... See more keywords